
NATURE . COM {
}
Title:
Reversibility and recurrence of IGF-IR-induced mammary tumors | Oncogene
Description:
The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {π}
- Education
- Health & Fitness
- Science
Content Management System {π}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of nature.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {πΈ}
Display Ads {π―}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {π°}
Display Ads {π―}
$63,100 per month
Our analysis indicates Nature.com generates between $42,042 and $115,616 monthly online from display ads.
Keywords {π}
cancer, article, google, scholar, cas, growth, breast, insulinlike, receptor, factor, res, nature, oncogene, mammary, tumor, human, igfir, access, tumors, expression, cell, content, research, cookies, recurrence, jones, campbell, moorehead, transgenic, privacy, function, signaling, mouse, epithelial, transition, open, nat, type, monoclonal, antibody, pubmed, tumorigenesis, moody, ontario, data, petrik, targeting, development, model, transcriptional,
Topics {βοΈ}
nature portfolio permissions reprints privacy policy nature formalin-fixed paraffin-embedded tissues cancer research society tgf-beta-induced collagen expression c-myc-induced mammary adenocarcinomas advertising igf-ir-induced mammary tumors social media health research p19arf/p53 pathway lesions author information authors mammary gland development anti-igf-ir therapies real-time pcr primer conditional wnt-induced tumorigenesis targeting igf-ir author correspondence tumor-size-dependent regression endocrine-responsive breast cancer springerlink instant access personal data recombinant humanized anti-insulin tumor development igf-ir-independent mechanisms signal transduction function regulates epithelial plasticity data protection permissions invasive breast cancers transgenic mouse model igf-ir-dependent e-cadherin gene expression accelerates mammary tumorigenesis breast cancer cells kinase activity human breast cancer igf-ir dependence igf-ir independence human lung tumors igf-ir signaling igf-ir results growth factor receptor breast cancer panagiotis induces tumor formation metastasizing mammary carcinomas igf-ii mrna privacy
Questions {β}
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Reversibility and recurrence of IGF-IR-induced mammary tumors
description:The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
datePublished:2009-04-20T00:00:00Z
dateModified:2009-04-20T00:00:00Z
pageStart:2152
pageEnd:2162
sameAs:https://doi.org/10.1038/onc.2009.79
keywords:
insulin-like growth factor
mammary tumorigenesis
tumor recurrence
epithelial to mesenchymal transition
tumor dormancy
Medicine/Public Health
general
Internal Medicine
Cell Biology
Human Genetics
Oncology
Apoptosis
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig6_HTML.jpg
isPartOf:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Reversibility and recurrence of IGF-IR-induced mammary tumors
description:The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
datePublished:2009-04-20T00:00:00Z
dateModified:2009-04-20T00:00:00Z
pageStart:2152
pageEnd:2162
sameAs:https://doi.org/10.1038/onc.2009.79
keywords:
insulin-like growth factor
mammary tumorigenesis
tumor recurrence
epithelial to mesenchymal transition
tumor dormancy
Medicine/Public Health
general
Internal Medicine
Cell Biology
Human Genetics
Oncology
Apoptosis
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig6_HTML.jpg
isPartOf:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(127)
- How much profit does https://link.springer.com/article/10.1038/onc.2009.79?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle make?
- Monthly income for https://doi.org/10.1038%2Fnrc2256
- How much income does http://scholar.google.com/scholar_lookup?&title=Models%2C%20mechanisms%20and%20clinical%20evidence%20for%20cancer%20dormancy&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2256&volume=7&pages=834-846&publication_year=2007&author=Aguirre-Ghiso%2CJA have?
- https://doi.org/10.1038%2Fnrc721's financial summary
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Endocrine-responsive%20breast%20cancer%20and%20strategies%20for%20combating%20resistance&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc721&volume=2&pages=101-112&publication_year=2002&author=Ali%2CS&author=Coombes%2CRC each month?
- How much does https://doi.org/10.1172%2FJCI114315 make?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Blockade%20of%20the%20type%20I%20somatomedin%20receptor%20inhibits%20growth%20of%20human%20breast%20cancer%20cells%20in%20athymic%20mice&journal=J%20Clin%20Invest&doi=10.1172%2FJCI114315&volume=84&pages=1418-1423&publication_year=1989&author=Arteaga%2CC&author=Kitten%2CK&author=Coronado%2CE each month?
- Check the income stats for https://doi.org/10.1038%2Fbjc.1995.484
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Mammary%20cancer%20in%20transgenic%20mice%20expressing%20insulin-like%20growth%20factor%20II%20%28IGF-II%29&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.1995.484&volume=72&pages=1189-1193&publication_year=1995&author=Bates%2CP&author=Fisher%2CR&author=Ward%2CA&author=Richardson%2CL&author=Hill%2CDJ&author=Graham%2CCF
- How much revenue does https://doi.org/10.1016%2Fj.ccr.2004.10.013 bring in?
- How much does http://scholar.google.com/scholar_lookup?&title=Lack%20of%20sustained%20regression%20of%20c-MYC-induced%20mammary%20adenocarcinomas%20following%20brief%20or%20prolonged%20MYC%20inactivation&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2004.10.013&volume=6&pages=577-586&publication_year=2004&author=Boxer%2CRB&author=Jang%2CJW&author=Sintasath%2CL&author=Chodosh%2CLA earn?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14695208
- Income figures for http://scholar.google.com/scholar_lookup?&title=A%20fully%20human%20monoclonal%20antibody%20to%20the%20insulin-like%20growth%20factor%20I%20receptor%20blocks%20ligand-dependent%20signaling%20and%20inhibits%20human%20tumor%20growth%20in%20vivo&journal=Cancer%20Res&volume=63&pages=8912-8921&publication_year=2003&author=Burtrum%2CD&author=Zhu%2CZ&author=Lu%2CD&author=Anderson%2CDM&author=Prewett%2CM&author=Pereira%2CDS
- Revenue of https://doi.org/10.1158%2F0008-5472.CAN-04-4602
- http://scholar.google.com/scholar_lookup?&title=Tumor%20development%20by%20transgenic%20expression%20of%20a%20constitutively%20active%20insulin-like%20growth%20factor%20I%20receptor&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-04-4602&volume=65&pages=3781-3787&publication_year=2005&author=Carboni%2CJM&author=Lee%2CAV&author=Hadsell%2CDL&author=Rowley%2CBR&author=Lee%2CFY&author=Bol%2CDK income
- What's the income generated by https://doi.org/10.1158%2F0008-5472.CAN-06-2044 each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Mesenchymal-to-epithelial%20transition%20facilitates%20bladder%20cancer%20metastasis%3A%20role%20of%20fibroblast%20growth%20factor%20receptor-2&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-2044&volume=66&pages=11271-11278&publication_year=2006&author=Chaffer%2CCL&author=Brennan%2CJP&author=Slavin%2CJL&author=Blick%2CT&author=Thompson%2CEW&author=Williams%2CED rake in every month?
- What are the earnings of https://doi.org/10.1038%2Fsj.cgt.7700126?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20human%20breast%20cancer%20cells%20with%20antisense%20RNA%20to%20the%20type%20I%20insulin-like%20growth%20factor%20receptor%20inhibits%20cell%20growth%2C%20suppresses%20tumorigenesis%2C%20alters%20the%20metastatic%20potential%2C%20and%20prolongs%20survival%20in%20vivo&journal=Cancer%20Gene%20Ther&doi=10.1038%2Fsj.cgt.7700126&volume=7&pages=384-395&publication_year=2000&author=Chernicky%2CCL&author=Yi%2CL&author=Tan%2CH&author=Gan%2CSU&author=Ilan%2CJ
- Income figures for https://doi.org/10.1038%2F84691
- How much does http://scholar.google.com/scholar_lookup?&title=c-MYC%20induces%20mammary%20tumorigenesis%20by%20means%20of%20a%20preferred%20pathway%20involving%20spontaneous%20Kras2%20mutations&journal=Nat%20Med&doi=10.1038%2F84691&volume=7&pages=235-239&publication_year=2001&author=D%E2%80%99Cruz%2CCM&author=Gunther%2CEJ&author=Boxer%2CRB&author=Hartman%2CJL&author=Sintasath%2CL&author=Moody%2CSE bring in each month?
- What's the financial outcome of https://doi.org/10.1172%2FJCI33320?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor%20escape%20in%20a%20Wnt1-dependent%20mouse%20breast%20cancer%20model%20is%20enabled%20by%20p19Arf%2Fp53%20pathway%20lesions%20but%20not%20p16%20Ink4a%20loss&journal=J%20Clin%20Invest&doi=10.1172%2FJCI33320&volume=118&pages=51-63&publication_year=2008&author=Debies%2CMT&author=Gestl%2CSA&author=Mathers%2CJL&author=Mikse%2COR&author=Leonard%2CTL&author=Moody%2CSE earn?
- How much does https://link.springer.com/doi/10.1007/s10549-006-9168-1 earn?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=The%20growth%20hormone%20receptor%20antagonist%20pegvisomant%20blocks%20both%20mammary%20gland%20development%20and%20MCF-7%20breast%20cancer%20xenograft%20growth&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-006-9168-1&volume=98&pages=315-327&publication_year=2006&author=Divisova%2CJ&author=Kuiatse%2CI&author=Lazard%2CZ&author=Weiss%2CH&author=Vreeland%2CF&author=Hadsell%2CDL
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9699666 rake in every month?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=A%20dominant%20negative%20mutant%20of%20the%20insulin-like%20growth%20factor-I%20receptor%20inhibits%20the%20adhesion%2C%20invasion%20and%20metastasis%20of%20breast%20cancer&journal=Cancer%20Res&volume=58&pages=3353-3361&publication_year=1998&author=Dunn%2CSE&author=Ehrlich%2CM&author=Sharp%2CNJ&author=Keiss%2CK&author=Solomon%2CG&author=Hawkins%2CR
- https://doi.org/10.1038%2Fsj.onc.1208429's revenue stream
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=DeltaEF1%20is%20a%20transcriptional%20repressor%20of%20E-cadherin%20and%20regulates%20epithelial%20plasticity%20in%20breast%20cancer%20cells&journal=Oncogene&doi=10.1038%2Fsj.onc.1208429&volume=24&pages=2375-2385&publication_year=2005&author=Eger%2CA&author=Aigner%2CK&author=Sonderegger%2CS&author=Dampier%2CB&author=Oehler%2CS&author=Schreiber%2CM each month?
- What's the income of https://doi.org/10.1158%2F1535-7163.MCT-05-0252?
- See how much http://scholar.google.com/scholar_lookup?&title=Novel%20human%20monoclonal%20antibodies%20to%20insulin-like%20growth%20factor%20%28IGF%29-II%20that%20potently%20inhibit%20the%20IGF%20receptor%20type%20I%20signal%20transduction%20function&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-05-0252&volume=5&pages=114-120&publication_year=2006&author=Feng%2CY&author=Zhu%2CZ&author=Xiao%2CX&author=Choudhry%2CV&author=Barrett%2CJC&author=Dimitrov%2CDS makes per month
- How much money does https://link.springer.com/doi/10.1007/BF01807035 generate?
- What's http://scholar.google.com/scholar_lookup?&title=IGF-II%20mRNA%20and%20protein%20are%20expressed%20in%20the%20stroma%20of%20invasive%20breast%20cancers%3A%20an%20in%20situ%20hybridization%20and%20immunohistochemistry%20study&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01807035&volume=41&pages=43-50&publication_year=1996&author=Giani%2CC&author=Cullen%2CKJ&author=Campani%2CD&author=Rasmussen%2CA's gross income?
- Earnings of https://doi.org/10.1002%2Fijc.20543
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=A%20recombinant%20humanized%20anti-insulin-like%20growth%20factor%20receptor%20type%20I%20antibody%20%28h7C10%29%20enhances%20the%20antitumor%20activity%20of%20vinorelbine%20and%20anti-epidermal%20growth%20factor%20receptor%20therapy%20against%20human%20cancer%20xenografts&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.20543&volume=113&pages=316-328&publication_year=2005&author=Goetsch%2CL&author=Gonzalez%2CA&author=Leger%2CO&author=Beck%2CA&author=Pauwels%2CPJ&author=Haeuw%2CJF each month?
- What's the monthly money flow for https://doi.org/10.1101%2Fgad.1051603?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Impact%20of%20p53%20loss%20on%20reversal%20and%20recurrence%20of%20conditional%20Wnt-induced%20tumorigenesis&journal=Genes%20Dev&doi=10.1101%2Fgad.1051603&volume=17&pages=488-501&publication_year=2003&author=Gunther%2CEJ&author=Moody%2CSE&author=Belka%2CGK&author=Hahn%2CKT&author=Innocent%2CN&author=Dugan%2CKD
- How much does https://doi.org/10.1038%2Fsj.onc.1203386 pull in monthly?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Cooperative%20interaction%20between%20mutant%20p53%20and%20des%281-3%29IGF-I%20accelerates%20mammary%20tumorigenesis&journal=Oncogene&doi=10.1038%2Fsj.onc.1203386&volume=19&pages=889-898&publication_year=2000&author=Hadsell%2CDL&author=Murphy%2CKL&author=Bonnette%2CSG&author=Reece%2CN&author=Laucirica%2CR&author=Rosen%2CJM
- How much income is https://doi.org/10.1158%2F1078-0432.CCR-07-1118 earning monthly?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Phase%20I%20dose%20escalation%20study%20of%20the%20anti%20insulin-like%20growth%20factor-I%20receptor%20monoclonal%20antibody%20CP-751%2C871%20in%20patients%20with%20refractory%20solid%20tumors&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1118&volume=13&pages=5834-5840&publication_year=2007&author=Haluska%2CP&author=Shaw%2CHM&author=Batzel%2CGN&author=Yin%2CD&author=Molina%2CJR&author=Molife%2CLR
- How much does https://doi.org/10.1016%2FS0140-6736%2897%2910384-1 rake in every month?
- http://scholar.google.com/scholar_lookup?&title=Circulating%20concentrations%20of%20insulin-like%20growth%20factor-I%20and%20risk%20of%20breast%20cancer&journal=Lancet&doi=10.1016%2FS0140-6736%2897%2910384-1&volume=351&pages=1393-1396&publication_year=1998&author=Hankinson%2CSE&author=Willett%2CWC&author=Colditz%2CGA&author=Hunter%2CDJ&author=Michaud%2CDS&author=Deroo%2CB's financial summary
- How much does https://doi.org/10.1056%2FNEJMra043186 make?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Trastuzumab%E2%80%94mechanism%20of%20action%20and%20use%20in%20clinical%20practice&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMra043186&volume=357&pages=39-51&publication_year=2007&author=Hudis%2CCA?
- How much does https://doi.org/10.1002%2Fjcp.21223 gross monthly?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20and%20mesenchymal-epithelial%20transitions%20in%20carcinoma%20progression&journal=J%20Cell%20Physiol&doi=10.1002%2Fjcp.21223&volume=213&pages=374-383&publication_year=2007&author=Hugo%2CH&author=Ackland%2CML&author=Blick%2CT&author=Lawrence%2CMG&author=Clements%2CJA&author=Williams%2CED
- What's the total monthly financial gain of https://doi.org/10.1038%2Fsj.onc.1209955?
- http://scholar.google.com/scholar_lookup?&title=Transgenic%20overexpression%20of%20IGF-IR%20disrupts%20mammary%20ductal%20morphogenesis%20and%20induces%20tumor%20formation&journal=Oncogene&doi=10.1038%2Fsj.onc.1209955&volume=26&pages=1636-1644&publication_year=2007&author=Jones%2CRA&author=Campbell%2CCI&author=Gunther%2CEJ&author=Chodosh%2CLA&author=Petrik%2CJJ&author=Khokha%2CR's financial summary
- What are the earnings of https://doi.org/10.1158%2F1541-7786.MCR-07-2157?
- http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20a%20novel%20primary%20mammary%20tumor%20cell%20line%20reveals%20that%20cyclin%20D1%20is%20regulated%20by%20the%20type%20I%20insulin-like%20growth%20factor%20receptor&journal=Mol%20Cancer%20Res&doi=10.1158%2F1541-7786.MCR-07-2157&volume=6&pages=819-828&publication_year=2008&author=Jones%2CRA&author=Campbell%2CCI&author=Petrik%2CJJ&author=Moorehead%2CRA income
- https://doi.org/10.1073%2Fpnas.0611192104's total income per month
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=MicroRNA-192%20in%20diabetic%20kidney%20glomeruli%20and%20its%20function%20in%20TGF-beta-induced%20collagen%20expression%20via%20inhibition%20of%20E-box%20repressors&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0611192104&volume=104&pages=3432-3437&publication_year=2007&author=Kato%2CM&author=Zhang%2CJ&author=Wang%2CM&author=Lanting%2CL&author=Yuan%2CH&author=Rossi%2CJJ?
- Earnings of https://doi.org/10.2325%2Fjbcs.954
- What's the income of http://scholar.google.com/scholar_lookup?&title=Current%20clinical%20trials%20of%20endocrine%20therapy%20for%20breast%20cancer&journal=Breast%20Cancer&doi=10.2325%2Fjbcs.954&volume=14&pages=200-214&publication_year=2007&author=Kurebayashi%2CJ?
- How much does https://doi.org/10.1016%2FS0304-3835%2803%2900159-9 gross monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=The%20insulin-like%20growth%20factor%20system%20and%20cancer&journal=Cancer%20Lett&doi=10.1016%2FS0304-3835%2803%2900159-9&volume=195&pages=127-137&publication_year=2003&author=LeRoith%2CD&author=Roberts%2CCT have?
- https://doi.org/10.1002%2Fijc.20814's total income per month
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Use%20of%20a%20transgenic%20mouse%20model%20to%20identify%20markers%20of%20human%20lung%20tumors&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.20814&volume=114&pages=977-982&publication_year=2005&author=Linnerth%2CNM&author=Sirbovan%2CK&author=Moorehead%2CRA?
- How much revenue does https://doi.org/10.1093%2Fjnci%2F93.24.1852 produce monthly?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor-I%20receptor%20signaling%20and%20resistance%20to%20trastuzumab%20%28Herceptin%29&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F93.24.1852&volume=93&pages=1852-1857&publication_year=2001&author=Lu%2CY&author=Zi%2CX&author=Zhao%2CY&author=Mascarenhas%2CD&author=Pollak%2CM
- How much revenue does https://doi.org/10.1016%2FS1535-6108%2804%2900050-9 bring in?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20the%20insulin-like%20growth%20factor%20receptor-1%20tyrosine%20kinase%20activity%20as%20a%20therapeutic%20strategy%20for%20multiple%20myeloma%2C%20other%20hematologic%20malignancies%2C%20and%20solid%20tumors&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2804%2900050-9&volume=5&pages=221-230&publication_year=2004&author=Mitsiades%2CCS&author=Mitsiades%2CNS&author=McMullan%2CCJ&author=Poulaki%2CV&author=Shringarpure%2CR&author=Akiyama%2CM?
- Profit of https://doi.org/10.1016%2Fj.ccr.2005.07.009
- What's http://scholar.google.com/scholar_lookup?&title=The%20transcriptional%20repressor%20Snail%20promotes%20mammary%20tumor%20recurrence&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2005.07.009&volume=8&pages=197-209&publication_year=2005&author=Moody%2CSE&author=Perez%2CD&author=Pan%2CTC&author=Sarkisian%2CCJ&author=Portocarrero%2CCP&author=Sterner%2CCJ's gross income?
- Find out how much https://doi.org/10.1016%2FS1535-6108%2802%2900212-X earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=Conditional%20activation%20of%20Neu%20in%20the%20mammary%20epithelium%20of%20transgenic%20mice%20results%20in%20reversible%20pulmonary%20metastasis&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2802%2900212-X&volume=2&pages=451-461&publication_year=2002&author=Moody%2CSE&author=Sarkisian%2CCJ&author=Hahn%2CKT&author=Gunther%2CEJ&author=Pickup%2CS&author=Dugan%2CKD net monthly?
- How much revenue does https://doi.org/10.1038%2Fsj.onc.1210379 bring in?
- Profit of http://scholar.google.com/scholar_lookup?&title=Trastuzumab%3A%20triumphs%20and%20tribulations&journal=Oncogene&doi=10.1038%2Fsj.onc.1210379&volume=26&pages=3637-3643&publication_year=2007&author=Nahta%2CR&author=Esteva%2CFJ
- What are the total earnings of https://doi.org/10.1016%2Fj.bcp.2007.10.032?
- Get to know http://scholar.google.com/scholar_lookup?&title=Expression%20of%20cytochrome%20P450%202A5%20in%20a%20glucose-6-phosphate%20dehydrogenase-deficient%20mouse%20model%20of%20oxidative%20stress&journal=Biochem%20Pharmacol&doi=10.1016%2Fj.bcp.2007.10.032&volume=75&pages=1230-1239&publication_year=2008&author=Nichols%2CKD&author=Kirby%2CGM's earnings
- Find out how much https://link.springer.com/doi/10.1007/BF01833331 earns monthly
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20IGF-I%20and%20IGF-II%20mRNA%20in%20breast%20tissue&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01833331&volume=22&pages=31-38&publication_year=1992&author=Paik%2CS?
- Learn about the earnings of https://doi.org/10.1038%2Fsj.bjc.6690112
- Profit of http://scholar.google.com/scholar_lookup?&title=Altered%20expression%20of%20the%20IGF-1%20receptor%20in%20a%20tamoxifen-resistant%20human%20breast%20cancer%20cell%20line&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6690112&volume=79&pages=693-700&publication_year=1999&author=Parisot%2CJP&author=Hu%2CXF&author=DeLuise%2CM&author=Zalcberg%2CJR
- What is the monthly revenue of https://doi.org/10.1093%2Fnar%2Fgkj155?
- How much does http://scholar.google.com/scholar_lookup?&title=RTPrimerDB%3A%20the%20real-time%20PCR%20primer%20and%20probe%20database%2C%20major%20update%202006&journal=Nucleic%20Acids%20Res&doi=10.1093%2Fnar%2Fgkj155&volume=34&pages=D684-D688&publication_year=2006&author=Pattyn%2CF&author=Robbrecht%2CP&author=De%2CPA&author=Speleman%2CF&author=Vandesompele%2CJ gross monthly?
- What's the financial outcome of https://doi.org/10.1038%2Fnrc2131?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Snail%2C%20Zeb%20and%20bHLH%20factors%20in%20tumour%20progression%3A%20an%20alliance%20against%20the%20epithelial%20phenotype%3F&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2131&volume=7&pages=415-428&publication_year=2007&author=Peinado%2CH&author=Olmeda%2CD&author=Cano%2CA
- Discover the revenue of https://doi.org/10.1073%2Fpnas.0801197105
- How much income does http://scholar.google.com/scholar_lookup?&title=Oncogene%20cooperation%20in%20tumor%20maintenance%20and%20tumor%20recurrence%20in%20mouse%20mammary%20tumors%20induced%20by%20Myc%20and%20mutant%20Kras&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0801197105&volume=105&pages=5242-5247&publication_year=2008&author=Podsypanina%2CK&author=Politi%2CK&author=Beverly%2CLJ&author=Varmus%2CHE have?
- How much income does https://doi.org/10.1038%2Fnrc1387 have?
- http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factors%20and%20neoplasia&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1387&volume=4&pages=505-518&publication_year=2004&author=Pollak%2CMN&author=Schernhammer%2CES&author=Hankinson%2CSE's financial summary
- What's the revenue for https://doi.org/10.1002%2F%28SICI%291097-010X%2819980501%29281%3A1%3C43%3A%3AAID-JEZ7%3E3.0.CO%3B2-C?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Metastasizing%20mammary%20carcinomas%20in%20H19%20enhancers-Igf2%20transgenic%20mice&journal=J%20Exp%20Zool&doi=10.1002%2F%28SICI%291097-010X%2819980501%29281%3A1%3C43%3A%3AAID-JEZ7%3E3.0.CO%3B2-C&volume=281&pages=43-57&publication_year=1998&author=Pravtcheva%2CDD&author=Wise%2CTL?
- How much does https://doi.org/10.1016%2FS0140-6736%2804%2916044-3 pull in?
- See how much http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20%28IGF%29-I%2C%20IGF%20binding%20protein-3%2C%20and%20cancer%20risk%3A%20systematic%20review%20and%20meta-regression%20analysis&journal=Lancet&doi=10.1016%2FS0140-6736%2804%2916044-3&volume=363&pages=1346-1353&publication_year=2004&author=Renehan%2CAG&author=Zwahlen%2CM&author=Minder%2CC&author=O%E2%80%99Dwyer%2CST&author=Shalet%2CSM&author=Egger%2CM makes per month
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9515800
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Elevated%20insulin-like%20growth%20factor%20I%20receptor%20autophosphorylation%20and%20kinase%20activity%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=58&pages=1159-1164&publication_year=1998&author=Resnik%2CJL&author=Reichart%2CDB&author=Huey%2CK&author=Webster%2CNJG&author=Seely%2CBL?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-07-1109 generate monthly?
- http://scholar.google.com/scholar_lookup?&title=IMC-A12%2C%20a%20human%20IgG1%20monoclonal%20antibody%20to%20the%20insulin-like%20growth%20factor%20I%20receptor&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1109&volume=13&pages=5549s-5555s&publication_year=2007&author=Rowinsky%2CEK&author=Youssoufian%2CH&author=Tonra%2CJR&author=Solomon%2CP&author=Burtrum%2CD&author=Ludwig%2CDL's financial summary
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7757999?
- How much does http://scholar.google.com/scholar_lookup?&title=Malignant%20breast%20epithelium%20selects%20for%20insulin-like%20growth%20factor%20II%20expression%20in%20breast%20stroma%3A%20evidence%20for%20paracrine%20function&journal=Cancer%20Res&volume=55&pages=2448-2454&publication_year=1995&author=Singer%2CC&author=Rasmussen%2CA&author=Smith%2CHS&author=Lippman%2CME&author=Lynch%2CHT&author=Cullen%2CKJ make?
- How much does https://doi.org/10.1056%2FNEJM200103153441101 gross monthly?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Use%20of%20chemotherapy%20plus%20a%20monoclonal%20antibody%20against%20HER2%20for%20metastatic%20breast%20cancer%20that%20overexpresses%20HER2&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM200103153441101&volume=344&pages=783-792&publication_year=2001&author=Slamon%2CDJ&author=Leyland-Jones%2CB&author=Shak%2CS&author=Fuchs%2CH&author=Paton%2CV&author=Bajamonde%2CA
- What's the income of https://doi.org/10.1023%2FA%3A1009523501499?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Function%20of%20the%20IGF-I%20receptor%20in%20breast%20cancer&journal=J%20Mam%20Gland%20Biol%20Neoplasia&doi=10.1023%2FA%3A1009523501499&volume=5&pages=95-105&publication_year=2000&author=Surmacz%2CE?
- Income figures for https://doi.org/10.1016%2Fj.bbrc.2007.11.151
- How much does http://scholar.google.com/scholar_lookup?&title=Twist%20is%20a%20transcriptional%20repressor%20of%20E-cadherin%20gene%20expression%20in%20breast%20cancer&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2007.11.151&volume=367&pages=235-241&publication_year=2008&author=Vesuna%2CF&author=van%2CDP&author=Chen%2CJH&author=Raman%2CV rake in every month?
- What's the total monthly financial gain of https://doi.org/10.1016%2Fj.cell.2004.06.006?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Twist%2C%20a%20master%20regulator%20of%20morphogenesis%2C%20plays%20an%20essential%20role%20in%20tumor%20metastasis&journal=Cell&doi=10.1016%2Fj.cell.2004.06.006&volume=117&pages=927-939&publication_year=2004&author=Yang%2CJ&author=Mani%2CSA&author=Donaher%2CJL&author=Ramaswamy%2CS&author=Itzykson%2CRA&author=Come%2CC make?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3180080 each month?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20II%20mRNA%20expression%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=48&pages=6691-6696&publication_year=1988&author=Yee%2CD&author=Cullen%2CKJ&author=Paik%2CS&author=Perdue%2CJF&author=Hampton%2CB&author=Schwartz%2CA?
- Learn how profitable https://doi.org/10.1210%2Fmend-3-3-509 is on a monthly basis
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20insulin-like%20growth%20factor%20I%20gene%20expression%20in%20malignancy%3A%20evidence%20for%20a%20paracrine%20role%20in%20human%20breast%20cancer&journal=Mol%20Endocrinol&doi=10.1210%2Fmend-3-3-509&volume=3&pages=509-517&publication_year=1989&author=Yee%2CD&author=Paik%2CS&author=Lebovic%2CGS&author=Marcus%2CRR&author=Favoni%2CRE&author=Cullen%2CKJ?
- https://citation-needed.springer.com/v2/references/10.1038/onc.2009.79?format=refman&flavour=references's total income per month
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20A%20Jones generate?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20A%20Jones%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C%20I%20Campbell bring in?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C%20I%20Campbell%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G%20A%20Wood is on a monthly basis
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G%20A%20Wood%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%20J%20Petrik bring in each month?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%20J%20Petrik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20A%20Moorehead earning monthly?
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20A%20Moorehead%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income generated by https://s100.copyright.com/AppDispatchServlet?title=Reversibility%20and%20recurrence%20of%20IGF-IR-induced%20mammary%20tumors&author=R%20A%20Jones%20et%20al&contentID=10.1038%2Fonc.2009.79©right=Macmillan%20Publishers%20Limited&publication=0950-9232&publicationDate=2009-04-20&publisherName=SpringerNature&orderBeanReset=true each month?
- Income figures for https://citation-needed.springer.com/v2/references/10.1038/onc.2009.79?format=refman&flavour=citation
- How much money does https://doi.org/10.1038/s41388-018-0362-5 generate?
- What are the total earnings of https://doi.org/10.1186/s12943-015-0291-7?
- What's the income of https://doi.org/10.1038/onc.2013.373?
- How much does https://doi.org/10.1038/onc.2012.4 earn?
- https://doi.org/10.1007/s12282-011-0299-9's total income per month
- Monthly income for https://www.protocols.io/
- How much does https://www.natureindex.com/ gross monthly?
- How much money does http://www.naturechina.com generate?
- How much does https://www.natureasia.com/ja-jp make?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Prism.js
- Zoom.js
Emails and Hosting {βοΈ}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {π¦}
- Crossref